Sana Biotechnology (SANA) EPS (Basic) (2020 - 2026)
Sana Biotechnology (SANA) reported EPS (Basic) of -$0.59 for Q1 2026, up 35.78% on a YoY basis from -$0.43 in Q1 2025, and down 142.77% sequentially from -$0.24 in Q4 2025.
Sana Biotechnology (SANA) EPS (Basic) (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of EPS (Basic) data on file, last reported at -$0.59 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 35.78% year-over-year to -$0.59; the trailing twelve-month figure through Mar 2026 stood at -$1.93 (up 0.58% YoY), and the FY2025 full-year result was -$1.46, up 3.77% from the prior year.
- EPS (Basic) declined to -$0.59 in Q1 2026, from -$0.24 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.0 in Q3 2023 to a low of -$2.53 in Q4 2023.
- A 5-year average of -$0.77 and a median of -$0.59 in 2026 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 101.11% in 2023 and slumped 5195.59% in 2024, its largest moves.
- Tracing SANA's EPS (Basic) over 5 years: stood at -$0.44 in 2022, then sank by 472.37% to -$2.53 in 2023, then soared by 91.05% to -$0.23 in 2024, then slipped by 6.52% to -$0.24 in 2025, then tumbled by 142.77% to -$0.59 in 2026.
- Business Quant data shows SANA's EPS (Basic) at -$0.59 in Q1 2026, -$0.24 in Q4 2025, and -$0.33 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Sana Biotechnology | 881.79 Mn | 881.79 Mn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.59 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.94 |
| Mar 31, 2025 | -0.91 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.56 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | -2.53 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -1.82 |
| Mar 31, 2023 | -0.99 |
| Dec 31, 2022 | -0.44 |
| Sep 30, 2022 | -0.45 |
| Jun 30, 2022 | -0.76 |
| Mar 31, 2022 | -1.16 |
| Dec 31, 2021 | -1.62 |
| Sep 30, 2021 | -1.40 |
| Jun 30, 2021 | -0.09 |